CVE DATABASE / CVE-2026-45321
CVE-2026-45321
TanStack Unspecified Vulnerability
Confirmed exploited in the wild. Added 2026-05-27.
Federal remediation due 2026-06-10.
Required action: Apply mitigations per vendor instructions, follow applicable BOD 22-01 guidance for cloud services, or discontinue use of the product if mitigations are unavailable.
Summary
On 2026-05-11, between approximately 19:20 and 19:26 UTC, 84 malicious versions across 42 @tanstack/* packages were published to the npm registry. The publishes were authenticated via the legitimate GitHub Actions OIDC trusted-publisher binding for TanStack/router, but the publish workflow itself was not modified. The attacker chained three known vulnerability classes — a pull_request_target "Pwn Request" misconfiguration, GitHub Actions cache poisoning across the fork↔base trust boundary, and runtime memory extraction of the OIDC token from the Actions runner process — to publish credential-stealing malware under a trusted identity. Each affected package received exactly two malicious versions, published a few minutes apart.
CVSS 3.1 breakdown
| Base score | 9.6 (CRITICAL) |
| Vector | CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:H |
| Attack vector | NETWORK |
| Attack complexity | LOW |
| Privileges required | NONE |
| User interaction | REQUIRED |
| Scope | CHANGED |
| Confidentiality | HIGH |
| Integrity | HIGH |
| Availability | HIGH |
Weakness type (CWE)
Affected products
Use our free CVE Lookup tool for the latest NVD record, or browse the full CISA KEV catalog.
References
- https://github.com/TanStack/router/issues/7383
- https://github.com/TanStack/router/security/advisories/GHSA-g7cv-rxg3-hmpx
- https://tanstack.com/blog/npm-supply-chain-compromise-postmortem
- https://www.stepsecurity.io/blog/mini-shai-hulud-is-back-a-self-spreading-supply-chain-attack-hits-the-npm-ecosystem
- https://www.cisa.gov/known-exploited-vulnerabilities-catalog?field_cve=CVE-2026-45321
Data: NIST NVD + CISA KEV. NVD last modified 2026-05-27. Always verify against the vendor advisory before acting.